Skip to content

CorMedix CRMD Operating Loss Carryforwards

Operating Loss Carryforwards at other companies

Hippo Holdings logo
Hippo HoldingsHIPO
$663.9M
Kopin logo
KopinKOPN
$136.4M+22.3%
Hippo Holdings logo
Hippo HoldingsHIPO
$543.8M
PepsiCo logo
PepsiCoPEP
$35.5B+4.4%
MSCI logo
MSCIMSCI
$29.8M+4.9%
FIP
FTAI Infrastructure Inc.FIP
$1B+48.1%

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:OperatingLossCarryforwards.

The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's operating loss carryforwards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's operating loss carryforwards?
CorMedix (CRMD) reported operating loss carryforwards of $91.5 in Q4 2025.
What is the long-term trend for CorMedix's operating loss carryforwards?
Over 2 years (2023 to 2025), CorMedix's operating loss carryforwards has grown at a -99.9% compound annual growth rate (CAGR), from $113.6M to $91.5.